Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abcam Transferrin Receptor Peptide, Synthetic, Human, Unconjugated, 1 mg

Catalog No. 502708163
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-8163 1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-8163 Supplier Abcam Supplier No. AB1012191MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Synthetic blocking peptide for use in blocking applications.

  • Target: Human Transferrin Receptor (CD71)
  • Type: Synthetic blocking peptide
  • Applications: BL
  • Purity: >70%
  • Species Reactivity: Human
  • Form: Liquid
  • Storage Buffer: pH 6.75; 0.87% Sodium chloride, 0.714% HEPES, 0.0584% EDTA, 0.001% Sorbitan monolaurate, ethoxylated

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Substrate Properties Peptide-based Substrate
Target Molecule Transferrin Receptor (Human)
Shipping Condition Blue Ice
Label or Dye Unconjugated
Reactivity Human
Buffer 0.87% sodium chloride, 0.714% HEPES, 0.0584% EDTA, 0.001% sorbitan monolaurate, ethoxylated, pH6.75
Concentration 1 mg/mL
Product Type Blocker and Diluent
Content And Storage Store at -20°C.
Form Liquid
Cross Reactivity Human
Formulation pH 6.75, 0.87% Sodium chloride, 0.714% HEPES, 0.0584% EDTA, 0.001% Sorbitan monolaurate, ethoxylated
Quantity 1 mg
For Use With (Application) Blocking, Neutralization
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.